An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is one of the most widespread degenerative disorders in elderly people. A 90-day, open-label clinical study was conducted in 40 patients, aged 50 years or older, with early-stage dry-type AMD to evaluate the safety and efficacy of Macumax(®), a novel mixture of...

Descripción completa

Detalles Bibliográficos
Autores principales: Majeed, Muhammed, Majeed, Shaheen, Nagabhushanam, Kalyanam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Full Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140349/
https://www.ncbi.nlm.nih.gov/pubmed/33180005
http://dx.doi.org/10.1089/jmf.2020.0097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140349/
https://www.ncbi.nlm.nih.gov/pubmed/33180005
http://dx.doi.org/10.1089/jmf.2020.0097

Ejemplares similares